Page 152 - Read Online

Page 12 of 12 Park et al. J Cancer Metastasis Treat 2019;5:17 I http://dx.doi.org/10.20517/2394-4722.2018.84

cancer metastasis. Oncotarget 2015;6:20697-710.
3. Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2013;13:11-26.
4. Park J, Kim S, Joh J, Remick SC, Miller DM, et al. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase
signaling. Oncotarget 2016;7:43960-73.
5. Zimmerman T, Blanco FJ. Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: design and mechanism of action. Curr Pharm
Des 2008;14:2128-39.
6. Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep 2009;61:22-32.
7. Ogawa Y, Hirakawa K, Nakata B, Fujihara T, Sawada T, et al. Expression of intercellular adhesion molecule-1 in invasive breast cancer
reflects low growth potential, negative lymph node involvement, and good prognosis. Clin Cancer Res 1998;4:31-6.
8. Maeda K, Kang SM, Sawada T, Nishiguchi Y, Yashiro M, et al. Expression of intercellular adhesion molecule-1 and prognosis in colorectal
cancer. Oncol Rep 2002;9:511-4.
9. Anastassiou G, Schilling H, Stang A, Djakovic S, Heiligenhaus A, et al. Expression of the cell adhesion molecules ICAM-1, VCAM-1 and
NCAM in uveal melanoma: a clinicopathological study. Oncology 2000;58:83-8.
10. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, et al. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis
2005;26:943-50.
11. Kotteas EA, Boulas P, Gkiozos I, Tsagkouli S, Tsoukalas G, et al. The intercellular cell adhesion molecule-1 (icam-1) in lung cancer:
implications for disease progression and prognosis. Anticancer Res 2014;34:4665-72.
12. Melis M, Spatafora M, Melodia A, Pace E, Gjomarkaj M, et al. ICAM-1 expression by lung cancer cell lines: effects of upregulation by
cytokines on the interaction with LAK cells. Eur Respir J 1996;9:1831-8.
13. Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B. Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells
via upregulation of ICAM-1. Biochem Pharmacol 2014;92:312-25.
14. Jenkins DE, Hornig YS, Oei Y, Dusich J, Purchio T. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo
detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res 2005;7:R444-54.
15. Park JO, Park SH, Hong ST. A new method for transduction of mesenchymal stem cells using mechanical agitation. Mol Cells
2009;28:515-20.
16. Gregory CD, Murray RJ, Edwards CF, Rickinson AB. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr
virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 1988;167:1811-24.
17. Melotti P, Nicolis E, Tamanini A, Rolfini R, Pavirani A, et al. Activation of NF-kB mediates ICAM-1 induction in respiratory cells exposed
to an adenovirus-derived vector. Gene Ther 2001;8:1436-42.
18. Nejak-Bowen K, Kikuchi A, Monga SP. Beta-catenin-NF-kappaB interactions in murine hepatocytes: a complex to die for. Hepatology
2013;57:763-74.
19. Ma B, Hottiger MO. Crosstalk between Wnt/beta-catenin and NF-kappaB signaling pathway during inflammation. Front Immunol
2016;7:378.
20. Deng J, Miller SA, Wang HY, Xia W, Wen Y, et al. Beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer.
Cancer Cell 2002;2:323-34.
21. Hogg N, Patzak I, Willenbrock F. The insider's guide to leukocyte integrin signalling and function. Nat Rev Immunol 2011;11:416-26.
22. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994;343:831-6.
23. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-6.
24. Lanitis E, Irving M, Coukos G. Targeting the tumor vasculature to enhance T cell activity. Curr Opin Immunol 2015;33:55-63.
25. Bouzin C, Feron O. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery. Drug Resist
Updat 2007;10:109-20.
26. Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G. Endothelial intercellular adhesion molecule-1 expression is
suppressed in human malignancies: the role of angiogenic factors. Cancer Res 1996;56:1111-17.
27. Lanitis E, Dangaj D, Irving M, Coukos G. Mechanisms regulating T-cell infiltration and activity in solid tumors. Ann Oncol
2017;28:xii18-32.
28. Azuma A, Yagita H, Matsuda H, Okumura K, Niitani H. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell
lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell
cytotoxicity. Cancer Res 1992;52:4890-4.
29. Mentzer SJ, Rothlein R, Springer TA, Faller DV. Intercellular adhesion molecule-1 (ICAM-1) is involved in the cytolytic T lymphocyte
interaction with a human synovial cell line. J Cell Physiol 1988;137:173-8.
30. Anichini A, Mortarini R, Alberti S, Mantovani A, Parmiani G. T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to
by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis. Int J Cancer 1993;53:994-1001.
31. Anichini A, Mortarini R, Supino R, Parmiani G. Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on
the basis of ICAM-1 phenotype, VLA profile and invasive ability. Int J Cancer 1990;46:508-15.